These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28670978)

  • 1. A novel BLK-induced tumor model.
    Petersen DL; Berthelsen J; Willerslev-Olsen A; Fredholm S; Dabelsteen S; Bonefeld CM; Geisler C; Woetmann A
    Tumour Biol; 2017 Jul; 39(7):1010428317714196. PubMed ID: 28670978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
    Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
    Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
    Petersen DL; Krejsgaard T; Berthelsen J; Fredholm S; Willerslev-Olsen A; Sibbesen NA; Bonefeld CM; Andersen MH; Francavilla C; Olsen JV; Hu T; Zhang M; Wasik MA; Geisler C; Woetmann A; Odum N
    Leukemia; 2014 Oct; 28(10):2109-12. PubMed ID: 24919804
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
    Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
    Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.
    Malek SN; Dordai DI; Reim J; Dintzis H; Desiderio S
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7351-6. PubMed ID: 9636152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.
    Dymecki SM; Niederhuber JE; Desiderio SV
    Science; 1990 Jan; 247(4940):332-6. PubMed ID: 2404338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cells.
    Simpfendorfer KR; Armstead BE; Shih A; Li W; Curran M; Manjarrez-Orduño N; Lee AT; Diamond B; Gregersen PK
    Arthritis Rheumatol; 2015 Nov; 67(11):2866-76. PubMed ID: 26246128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.
    Texido G; Su IH; Mecklenbräuker I; Saijo K; Malek SN; Desiderio S; Rajewsky K; Tarakhovsky A
    Mol Cell Biol; 2000 Feb; 20(4):1227-33. PubMed ID: 10648608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.
    Yao XR; Scott DW
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7946-50. PubMed ID: 7690139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of selective irreversible inhibitors of B-Lymphoid tyrosine kinase (BLK).
    Fu T; Zuo Y; Zhong Z; Chen X; Pan Z
    Eur J Med Chem; 2022 Feb; 229():114051. PubMed ID: 34952433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 2,5-diaminopyrimidine derivatives as the first series of selective monomeric degraders of B-lymphoid tyrosine kinase.
    Fu T; Zuo Y; Xue G; Zhou D; Pan Z
    Eur J Med Chem; 2023 Aug; 256():115460. PubMed ID: 37163946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells.
    Samuelson EM; Laird RM; Maue AC; Rochford R; Hayes SM
    Immunol Cell Biol; 2012 Jul; 90(6):620-9. PubMed ID: 21894171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
    Akerblad P; Sigvardsson M
    J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.
    Tretter T; Ross AE; Dordai DI; Desiderio S
    J Exp Med; 2003 Dec; 198(12):1863-73. PubMed ID: 14662906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase-independent potentiation of B cell antigen receptor-mediated signal transduction by the protein tyrosine kinase Src.
    Lin J; Tao J; Dyer RB; Herzog NK; Justement LB
    J Immunol; 1997 Nov; 159(10):4823-33. PubMed ID: 9366407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.
    Winiarska M; Bojarczuk K; Pyrzynska B; Bil J; Siernicka M; Dwojak M; Bobrowicz M; Miazek N; Zapala P; Zagozdzon A; Krol M; Syta A; Podszywalow-Bartnicka P; Pilch Z; Dabrowska-Iwanicka A; Juszczynski P; Efremov DG; Slabicki M; Zenz T; Le Roy A; Olive D; Rygiel TP; Leusen JH; Golab J
    MAbs; 2014; 6(5):1300-13. PubMed ID: 25517315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRC signaling is crucial in the growth of synovial sarcoma cells.
    Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.
    Wu YY; Georg I; Díaz-Barreiro A; Varela N; Lauwerys B; Kumar R; Bagavant H; Castillo-Martín M; El Salem F; Marañón C; Alarcón-Riquelme ME
    J Immunol; 2015 Jun; 194(12):5692-702. PubMed ID: 25972485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.